Search Results - "Luppino, I"

Imagery Rescripting on Guilt-Inducing Memories in OCD: A Single Case Series Study by Tenore, Katia, Basile, Barbara, Cosentino, Teresa, De Sanctis, Brunetto, Fadda, Stefania, Femia, Giuseppe, Gragnani, Andrea, Luppino, Olga I, Pellegrini, Valerio, Perdighe, Claudia, Romano, Giuseppe, Saliani, Angelo M, Mancini, Francesco

“…Criticism is thought to play an important role in obsessive-compulsive disorder (OCD), and obsessive behaviors have been considered as childhood strategies to…”
Get full text

Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study by Tursi, A, Mocci, G, Cuomo, A, Allegretta, L, Aragona, G, Colucci, R, Della Valle, N, Ferronato, A, Forti, G, Gaiani, F, Graziani, M G, Lorenzetti, R, Luzza, F, Paese, P, Penna, A, Pica, R, Piergallini, S, Pranzo, G, Rodino, S, Scarcelli, A, Zampaletta, C, Cicerone, C, Cocco, A, De' Angelis, G, Donnarumma, L, Franceschi, M, Gallina, S, Grasso, G, Larussa, T, Luppino, I, Faggiani, R, Fanigliulo, L, Pagnini, C, Perazzo, P, Sacco, R, Sebkova, L, Scorza, S, Serio, M, De Monti, A, Picchio, M, Elisei, W, Maconi, G

“…Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn's Disease (CD). The aim of this study was to compare the efficacy and safety of UST in…”
Get more information

P.02.11 WITHDRAWAL OF INFLIXIMAB (IFX) AFTER ACHIEVING REMISSION: OUTCOME IN A COHORT OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS by Luppino, I, Spagnuolo, R, Marasco, R, Cosco, C, Ruggiero, G, Cosco, V, Doldo, P

Get full text

Feasibility of capsule endoscopy in elderly patients with obscure gastrointestinal bleeding. An up-to-date report by Orlando, G, Luppino, I M, Lerose, M A, Gervasi, R, Amato, B, Silecchia, G, Puzziello, A

“…Anemia is the most common hematologic abnormality in older populations. Furthermore, iron deficiency anemia is common and merits investigation and treatment,…”
Get full text

Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report by Orlando, G, Luppino, I M, Gervasi, R, Lerose, M A, Amato, B, Spagnuolo, R, Marasco, R, Doldo, P, Puzziello, A

“…Jejunal diverticulosis is an uncommon disease and usually asymptomatic. It can be complicated not only by diverticulitis, but by hemorrhage, perforation,…”
Get full text

P.1.151: HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY by Marasco, R, Spagnuolo, R, Cosco, C, Cosco, V, Ruggiero, G, Luppino, I, Doldo, P

Get full text

BOC.01.9: ADHERENCE TO QUALITY PERFORMANCE MEASURES FOR ENDOSCOPY IN IBD: A NATIONWIDE ITALIAN SURVEY by Cassinotti, A., Luppino, I., Pumpo, R., Cuomo, A., Vassallo, R., Segato, S., Soncini, M., Di Paolo, M.C.

Get full text

P.07.36 REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION by Cicerone, C., Luppino, I., Erboso, M., Paese, P., Leo, P.

Get full text

PA.143 VALUTATION OF MYOSIN LIGHT CHAIN KINASE (MLCK) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN IN VIVO STUDY by Fedele, R, Spagnuolo, R, Cosimo, P, Ruggiero, G, Luppino, I, Cosco, V, Cosco, C, Marasco, R, Doldo, P

Get full text

P544 Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study by Mocci, G, Scaldaferri, F, Pugliese, D, Savarino, E, Bodini, G, Cuomo, A, Donnarumma, L, Maconi, G, Cataletti, G, Rodino, S, Sebkova, L, Ferronato, A, Gaiani, F, Marzo, M, Luppino, I, Paese, P, Elisei, W, Monterubbianesi, R, Faggiani, R, Napolitano, D, Grossi, L, Serio, M, Scarcelli, A, Lorenzetti, R, Allegretta, L, Rocco, G, Zampaletta, C, Bolognini, L, Meucci, C, Colucci, R, Tonti, P, Della Valle, N, Piga, R, Forti, G, Onidi, F M, Usai Satta, P, Picchio, M, Papa, A, Tursi, A

“…Abstract Background Ustekinumab (UST) is an interleukin-12/interleukin-23 receptor antagonist recently approved for treating ulcerative colitis (UC), but with…”
Get full text

T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY by Mocci, G., Maconi, G., Cataletti, G., Mantia, B., Serio, M., Scarcelli, A., Onidi, F.M., Pagnini, C., Graziani, M., Di Paolo, M., Pranzo, G., Luppino, I., Paese, P., Monterubbianesi, R., Faggiani, R., Ferronato, A., Perini, B., Savarino, E., Binaghi, L., Schiavoni, E., Napolitano, D., Scaldaferri, F., Papa, A., Lorenzetti, R., Pica, R., Cocco, A., Rodino, S., Sebkova, L., Zampaletta, C., Gaiani, F., Fanigliulo, L., Allegretta, L., Cuomo, A., Donnarumma, L., Della Valle, N., Forti, G., Dore, M., Antonelli, E., Bassotti, G., Iannelli, C., Aragona, G., Lauria, A., Piergallini, S., Colucci, R., Meucci, C., Usai Satta, P., Elisai, W., Tursi, A.

Get full text

P505 Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn’s disease: results from “long vedo” italian multicenter study by Mocci, G, Maconi, G, Onidi, F M, Cataletti, G, Elisei, W, Scaldaferri, F, Lorenzetti, R, Pagnini, C, Scarcelli, A, Graziani, M G, Di Paolo, M C, Pranzo, G, Luppino, I, Monterubbianesi, R, Faggiani, R, Ferronato, A, Savarino, E, Pica, R, Cocco, A, Rodino, S, Sebkova, L, Zampaletta, C, Gaiani, F, Fanigliulo, L, Allegretta, L, Cuomo, A, Donnarumma, L, Della Valle, N, Forti, G, Antonelli, E, Bassotti, G, Iannelli, C, Aragona, G, Lauria, A, Piergallini, S, Colucci, R, Binaghi, L, Meucci, C, Papa, A, Tursi, A

“…Abstract Background Current data about long-term use of vedolizumab (VDZ) in ulcerative colitis (UC) versus Crohn’s disease (CD) patients are limited. We aimed…”
Get full text

P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study by Mocci, G, Cuomo, A, Allegretta, L, Aragona, G, Colucci, R, Della Valle, N, Ferronato, A, Forti, G, Gaiani, F, Graziani, M G, Lorenzetti, R, Luzza, F, Penna, A, Pica, R, Piergallini, S, Rodinò, S, Scarcelli, A, Zampaletta, C, Cicerone, C, Cocco, A, De Angelis, G, Donnarumma, L, Pranzo, G, Franceschi, M, Gallina, S, Grasso, G, Larussa, T, Luppino, I, Faggiani, R, Fanigliulo, L, Pagnini, C, Perazzo, P, Sacco, R, Sebkova, L, Serio, M E, De Monti, A, Picchio, M, Elisei, W, Maconi, G, Tursi, A

“…Abstract Background Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn’s Disease (CD). The aim of this study was to compare the efficacy…”
Get full text